الثعلبة الأندروجينية عند النساء المصابات بفرط الأندروجين: عندما لا يوقف مينوكسيديل الموضعي تساقط الشعر

References

DOI: 10.1111/jdv.14624

Oral CPA can be considered to prevent progression of AGA in women with clinical or biochemical evidence of hyperandrogenism.

Cyproterone acetate is generally prescribed in combination with an oestrogen as an oral contraceptive in oral contraceptive pills (2 mg over 21 days or added to an oral contraceptive on days 1–10 at 5–50 mg per day for enhanced anti-androgen activity).

As AGA is a naturally progressive disease, therapy can have two required outcomes, namely stop of hair loss and induction of hair regrowth.